Title: LUNG TRANSPLANTATION
1LUNG TRANSPLANTATION
ISHLT
2009
2RECIPIENT AGE DISTRIBUTION FOR PEDIATRIC LUNG
RECIPIENTS - NUMBER (Transplants January 1986 -
June 2008)
ISHLT
Analysis includes living donor transplants
2009
3RECIPIENT AGE DISTRIBUTION FOR PEDIATRIC LUNG
RECIPIENTS - PERCENTAGE(Transplants January
1986 - June 2008)
ISHLT
Analysis includes living donor transplants
2009
4DONOR TYPE DISTRIBUTION BY YEAR OF TRANSPLANT FOR
PEDIATRIC LUNG RECIPIENTS (Transplants 1986-2007)
NOTE This figure includes only the lung
transplants that are reported to the ISHLT
Transplant Registry. As such, the presented data
may not mirror the changes in the number of lung
transplants performed worldwide.
ISHLT
2009
Analysis includes living donor transplants
5DONOR TYPE DISTRIBUTION BY RECIPIENT AGE GROUP
WITHIN ERA FOR PEDIATRIC LUNG RECIPIENTS
(Transplants January 1986 - June 2008)
ISHLT
Analysis includes living donor transplants
2009
6AGE DISTRIBUTION FOR DONORS OF PEDIATRIC LUNG
RECIPIENTS (Transplants January 1986 - June 2008)
ISHLT
2009
7AGE DISTRIBUTION OF PEDIATRIC LUNG RECIPIENTSBy
Year of Transplant
NOTE This figure includes only the pediatric
lung transplants that are reported to the ISHLT
Transplant Registry. Therefore, these numbers
should not be interpreted as the rate of change
in pediatric lung procedures performed worldwide.
ISHLT
2009
Analysis includes living donor transplants
8NUMBER OF CENTERS REPORTING PEDIATRIC LUNG
TRANSPLANTS
ISHLT
Analysis includes living donor transplants
2009
9NUMBER OF CENTERS REPORTING PEDIATRIC LUNG
TRANSPLANTS BY CENTER VOLUME
ISHLT
Analysis includes living donor transplants
2009
10PEDIATRIC LUNG TRANSPLANTATION Indications
(Transplants January 1990 June 2008)
ISHLT
Analysis includes living donor transplants
2009
11PEDIATRIC LUNG TRANSPLANTATIONOther Indications
(Transplants January 1990 June 2006)
ISHLT
Analysis includes living donor transplants
2009
Last updated based on data as of December 2006
12PEDIATRIC LUNG TRANSPLANTATION Other
Indications (Transplants January 1990 June
2006)
ISHLT
Analysis includes living donor transplants
2009
Last updated based on data as of December 2006
13PEDIATRIC LUNG TRANSPLANTATION Other
Indications (Transplants January 1990 June
2006)
ISHLT
Analysis includes living donor transplants
2009
Last updated based on data as of December 2006
14DIAGNOSIS IN PEDIATRIC LUNG RECIPIENTSBY YEAR OF
TRANSPLANTAge 12-17 Years
ISHLT
Analysis includes living donor transplants
2009
15PEDIATRIC LUNG TRANSPLANTSAGE DISTRIBUTION BY
LOCATION Transplants between January 2000 and
June 2008
ISHLT
Analysis includes living donor transplants
2009
16PEDIATRIC LUNG TRANSPLANTSDIAGNOSIS
DISTRIBUTION BY LOCATION Transplants between
January 2000 and June 2008
NOTE Unknown diagnoses were excluded from this
tabulation. Total number of transplants
reported Europe 171 North America 443 Other
35
ISHLT
2009
Analysis includes living donor transplants
17PEDIATRIC LUNG TRANSPLANTSDONOR AGE
DISTRIBUTION BY LOCATION Transplants between
January 2000 and June 2008
NOTE Transplants with unknown donor age and
living donor transplants were excluded from this
tabulation. Total number of transplants
reported Europe 181 North America 443 Other
35
ISHLT
2009
18LUNG TRANSPLANTATIONKaplan-Meier Survival by Age
Group (Transplants January 1990 - June 2007)
ISHLT
2009
19PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier
Survival by Procedure Type (Transplants January
1990 - June 2007)
ISHLT
2009
20PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier
Survival for Congenital Diagnoses (Transplants
January 1990 June 2007)
ISHLT
2009
21PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier
Survival by Age Group (Transplants January 1990
- June 2007)
ISHLT
2009
22PEDIATRIC LUNG TRANSPLANTATIONConditional
Kaplan-Meier Survival by Age Group(Transplants
January 1990 - June 2007)
ISHLT
2009
23PEDIATRIC LUNG TRANSPLANTATION Kaplan-Meier
Survival by Era (Transplants January 1988 - June
2007)
ISHLT
2009
24PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier
Survival by Donor Type for Recipients Age 12-17
Years(Transplants January 1990 - June 2007)
ISHLT
2009
25PEDIATRIC LUNG RE-TRANSPLANTS Between January
1994 and June 2008
Time Between Previous and Current Transplant
ISHLT
2009
26PEDIATRIC LUNG RETRANSPLANTSSurvival for
Transplants Performed Between January 1994 and
June 2007
ISHLT
2009
27PEDIATRIC LUNG RECIPIENTS Functional Status of
Surviving Recipients(Follow-ups April 1994-June
2008)
ISHLT
2009
28PEDIATRIC LUNG RECIPIENTS Functional Status of
Surviving RecipientsFor the Same
Patients(Follow-ups April 1994-June 2008)
ISHLT
2009
29PEDIATRIC LUNG RECIPIENTS Rehospitalization
Post-transplant of Surviving Recipients(Follow-up
s April 1994 - June 2008)
ISHLT
2009
30PEDIATRIC LUNG RECIPIENTS Rehospitalization
Post-transplant of Surviving Recipients(Follow-up
s April 1994 - June 2008)
ISHLT
2009
31PEDIATRIC LUNG RECIPIENTS Induction
ImmunosuppressionFor transplants between January
2001 and June 2008
ISHLT
Analysis is limited to patients who were alive at
the time of the follow-up
2009
32PEDIATRIC LUNG RECIPIENTSInduction
Immunosuppression (Transplants January 2001 -
June 2007)
ISHLT
Analysis is limited to patients who were alive at
the time of the follow-up
2009
33PEDIATRIC LUNG TRANSPLANTATIONKaplan-Meier
Survival Stratified by Induction Use
(Transplants January 2001 - June 2007)
ISHLT
2009
34PEDIATRIC LUNG RECIPIENTS Maintenance
Immunosuppression at Time of Follow-up(Follow-ups
January 2001 June 2008)
NOTE Different patients are analyzed in Year 1
and Year 5
ISHLT
Analysis is limited to patients who were alive at
the time of the follow-up
2009
35PEDIATRIC LUNG RECIPIENTS Maintenance
Immunosuppression at Time of Follow-up(Follow-ups
January 2001 June 2008)
1 Year Follow-up (N 272)
5 Year Follow-up (N 117)
NOTE Different patients are analyzed in Year 1
and Year 5
NOTE 4 of patients were on both calcineurin
inhibitors at different point during the year
these patients are not counted in either group.
And 1 (2 patients) was on neither drugs during
the year. In the 5-year tabulations, 13 were
reported to be on both drugs during the year and
1 (1 patient) was reported to be on neither
drugs.
ISHLT
2009
Analysis is limited to patients who were alive at
the time of the follow-up
36PEDIATRIC LUNG RECIPIENTS Maintenance
Immunosuppression Drug Combinations at Time of
Follow-up Report (Follow-ups January 2001
June 2008)
NOTE Different patients are analyzed in Year 1
and Year 5
ISHLT
Analysis is limited to patients who were alive at
the time of the follow-up
2009
37POST-LUNG TRANSPLANT MORBIDITY FOR PEDIATRICS
Cumulative Prevalence in Survivors within 1 Year
Post-Transplant (Follow-ups April 1994 - June
2008)
ISHLT
2009
38POST-LUNG TRANSPLANT MORBIDITY FOR PEDIATRICS
Cumulative Prevalence in Survivors within 5
Years Post-Transplant (Follow-ups April 1994 -
June 2008)
ISHLT
2009
39POST-LUNG TRANSPLANT MORBIDITY FOR PEDIATRICS
Cumulative Prevalence in Survivors within 7
Years Post-Transplant (Follow-ups April 1994 -
June 2008)
ISHLT
2009
40Freedom from Bronchiolitis Obliterans Syndrome
For Pediatric Lung Recipients (Follow-ups April
1994 - June 2008)
ISHLT
2009
41Freedom from Bronchiolitis Obliterans Syndrome
For Pediatric Lung Recipients by Induction Use
(Follow-ups April 1994 - June 2008)
ISHLT
2009
42Freedom from Severe Renal DysfunctionFor
Pediatric Lung Recipients (Follow-ups April 1994
- June 2008)
ISHLT
2009
43MALIGNANCY POST-LUNG TRANSPLANTATION FOR
PEDIATRICSCumulative Incidence for Survivors
(Follow-ups April 1994 - June 2008)
Other includes Liver and primitive
neuroectodermal tumor.
ISHLT
2009
44Freedom from MalignancyFor Pediatric Lung
Recipients (Follow-ups April 1994 - June 2008)
ISHLT
2009
45PEDIATRIC LUNG TRANSPLANT RECIPIENTS Cause Of
Death(Deaths January 1992- June 2008)
ISHLT
2009
46PEDIATRIC LUNG TRANSPLANT RECIPIENTS Other Cause
Of Death(Deaths January 1992- June 2006)
ISHLT
2009
Last updated based on data as of December 2006
47PEDIATRIC LUNG TRANSPLANT RECIPIENTS Relative
Incidence of Leading Causes of Death (Deaths
January 1992 - June 2008)
ISHLT
2009
48PEDIATRIC LUNG TRANSPLANT RECIPIENTS
(1/1990-6/2007) Risk Factors For 1 Year
Mortality/Graft Failure
N738
ISHLT
2009
49PEDIATRIC LUNG TRANSPLANT RECIPIENTS
(1/1990-6/2003) Risk Factors For 5 Year
Mortality/Graft Failure
N527
ISHLT
2009